Medline, Inc. (MDLN)
36.52
+0.52
(+1.43%)
USD |
NASDAQ |
Jun 10, 16:00
36.65
+0.12
(+0.34%)
After-Hours: 20:00
Medline EPS Diluted (Quarterly) : 0.1525 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.1525 |
| December 31, 2025 | 0.2241 |
| September 30, 2025 | 0.4026 |
| June 30, 2025 | 0.4164 |
| March 31, 2025 | 0.4026 |
| Date | Value |
|---|---|
| December 31, 2024 | 0.3613 |
| September 30, 2024 | 0.4051 |
| June 30, 2024 | 0.3651 |
| March 31, 2024 | 0.3688 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.6165 |
| Baxter International, Inc. | -0.0291 |
| Boston Scientific Corp. | 0.897 |
| Globus Medical, Inc. | 0.8995 |
| Penumbra, Inc. | 0.824 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 239.00M |
| Revenue (Quarterly) | 7.352B |
| Total Expenses (Quarterly) | 7.223B |
| Enterprise Value | 48.94B |
| Gross Profit Margin (Quarterly) | 22.65% |
| Profit Margin (Quarterly) | 3.25% |
| Earnings Yield | 3.27% |
| Operating Earnings Yield | 7.23% |
| Normalized Earnings Yield | 3.651 |